Cost-Effectiveness Analysis of Active Surveillance Compared to Early Surgery in Small Papillary Thyroid Cancer: A Systemic Review
Han-sang Baek,Chai-ho Jeong,Jeonghoon Ha,Ja-Seong Bae,Jeong-soo Kim,Dong-Jun Lim,Chul-Min Kim
DOI: https://doi.org/10.2147/CMAR.S317627
2021-08-26
Cancer Management and Research
Abstract:Han-sang Baek, 1 Chai-ho Jeong, 2 Jeonghoon Ha, 1 Ja-Seong Bae, 3 Jeong-soo Kim, 3 Dong-Jun Lim, 1 Chul-Min Kim 4 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Republic of Korea; 3 Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; 4 Department of Family Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea Correspondence: Dong-Jun Lim Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea Email Chul-Min Kim Department of Family Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea Email Papillary thyroid microcarcinoma (PTMC) has indolent features and low mortality. Recently, active surveillance (AS) instead of early surgery (ES) has been introduced as one treatment option but economical preference has not been established. The study objective was to systemically review the literature relating to cost-effectiveness of AS compared to ES for PTMC. Keywords were selected through PICO (Population, Intervention, Comparison, and Outcomes) tools. The search was conducted using PubMed, Cochrane, EMBASE, and Elsevier databases. Papers that had irrelevant titles were written in foreign languages, or had no original results were excluded. Out of the 62 papers extracted, five relevant to the subject matter of this study were identified. Three papers made their own decision models and proceeded with cost-effectiveness analysis (CEA), but the remaining two simply compared costs rather than cost-effectiveness. In terms of cost-effectiveness, three papers preferred AS, one preferred ES, and one preferred neither. The major differences in the CEA might arise from variations in each country's medical insurance system, the utility score systems, and decision models used. In subgroup analysis, two papers preferred AS to ES for patients at a younger age at diagnosis in terms of cost-effectiveness as well as tumor biological characteristics. Although AS has been generally more cost-effective than ES in previous publications, younger age at diagnosis could be one factor contributing to preference for ES. The CEA of prospective cohorts based on the decision model and utility score for thyroid cancer should be undertaken to confirm the cost-effectiveness of AS. Keywords: cost-effectiveness analysis, papillary thyroid cancer, quality of life, active surveillance, endocrine surgical procedures Although thyroid tumorigenesis is a complex process, most patients with differentiated thyroid cancer (DTC) exhibit slow tumor growth and have a good prognosis. 1 In Korea, while the incidence of thyroid cancer has increased rapidly since 2000, the 10-year survival rate of 94% is relatively high according to the 2018 Korean National Cancer registration data. 2 This trend is similar to that of worldwide data. 3 Papillary thyroid microcarcinoma (PTMC) with a diameter of less than 1 cm progresses slowly, is less aggressive, and has been detected more frequently in recent years. 4,5 Due to indolent features, low mortality of small thyroid cancer, and fear of surgical complications, active surveillance (AS) could be provided as a surrogate of early surgery (ES). In one meta-analysis about AS for PTMC, the maximum percentage of delayed operation in AS population was 32%, but the reason for delayed operation was others rather than size increase or lymph node metastasis. 6 And according to one retrospective study, the surgical complication rate was 1% for lobectomy and 17% for total thyroidectomy. 7 However, it is vague that how these factors influence the cost-effectiveness of AS for PTMC. And it is not clear that AS is cost-effective compared to ES considering the good prognosis and long-term follow-up nature of DTC. This nature also makes it essential to consider cost-effectiveness from a long-term perspective for patients, physicians, payers, and the government. However, as it is difficult to find well-designed conclusive studies on the cost-effectiveness analysis (CEA) of AS versus ES for PTMC in Korea and at a global level, a systemic review on the topic is necessary. Key -Abstract Truncated-
oncology